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Edited by Beat ImhofAbstract Wheat gliadin is the triggering agent in coeliac
disease. In this study, we documented that proteolytic fragments
of gliadin, in contrast to other food antigens, induced interleukin
(IL)-8 and tumour necrosis factor-a (TNF-a) production and
signiﬁcantly increased interferon (IFN)-c-induced cytokine se-
cretion in human monocytic line THP-1 cells. Stimulation with
gliadin resulted in elevated phosphorylation of the IjBa molecule
and increased NF-jB/DNA binding activity that was inhibited by
sulfasalazine, L-1-tosylamido-2-phenylethyl chloromethyl ketone
and pyrrolidine dithiocarbamate (PDTC). The activation path-
way was shown to be independent of the CD14 molecule. Less
mature U-937 monocytes responded to gliadin stimulation by low
IL-8 secretion, TNF-a production was not detectable. We
propose that gliadin-induced activation of monocytes/macro-
phages can participate in mechanisms leading to the impairment
of intestinal mucosa in coeliac patients.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Coeliac disease, a chronic inﬂammation of small intestine,
develops in genetically susceptible individuals because of
intolerance to wheat gluten and related prolamins. Gluten, a
complex mixture of gliadins and glutenins, is usually digested
in the gastrointestinal tract by various enzymes of human and
bacterial origin, mainly by pepsin in stomach.
Gliadin-peptide-speciﬁc CD4+ a=b T lymphocytes present in
jejunal mucosa seem to be central in the immunopathology of
the disease. After challenge, they produce increased levels of
inﬂammatory cytokines of T-helper 1 proﬁle (mainly interfer-
on-c, IFN-c) and other mediators that can activate other cell
types including cells of innate immunity. Macrophages and
dendritic cells in intestinal mucosa play a role as antigen pre-
senting cells and could be activated by various stimuli to the
production of inﬂammatory cytokines (such as tumour necrosis
factor-a (TNF-a), interleukin (IL)-1 and IL-6), chemokines* Corresponding author. Fax: +420-241-721-143.
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oxygen and nitrogen intermediates [1–4].
Although the vast majority of bacterial and food compo-
nents do not elicit intestinal inﬂammation, it is becoming in-
creasingly recognised that pathogens that cause acute
inﬂammation do activate the NF-jB pathway, resulting in a
regulation of genes encoding proinﬂammatory cytokines,
chemokines and adhesion molecules. The NF-jB family of
proteins consists of homo- and heterodimeric subunits of the
Rel family, including p50 and p65. The activity of NF-jB is
regulated by a family of IjB inhibitor proteins (IjB a, b, c and
e), which sequester NF-jB in the cytoplasm. Upon stimula-
tion, IjB is phosphorylated, ubiquitinated, and subsequently
degraded by the proteasome complex. Degradation of IjB
allows NF-jB to translocate to the nucleus, bind to its speciﬁc
promoter elements and activate gene transcription [5].
In recent years, the mechanism of activation of monocytes,
intestinal epithelial cells or macrophages and the involvement
of upregulated membrane expression and secretion of mole-
cules such as HLA-DR, CD95/Fas, intercellular cell adhesion
molecule-1 (ICAM-1), IL-15 or reactive nitric oxide (NO)
radicals in coeliac disease immunopathogeny became a topic of
intensive studies [6–10].
We have shown that wheat gliadin and its peptic fragments
have the unique ability, in contrast to other food proteins, to
activate the mouse peritoneal macrophages to the production
of TNF-a, IL-10, RANTES and an inducible form of NO
synthase. Gliadin fragments active in these processes were
isolated and identiﬁed [3,4].
The aim of the present study was to investigate whether food
proteins such as gliadin, soya protein or ovalbumin can also
activate human monocytic cell lines (THP-1 and U-937 dif-
fering in surface marker expression) to cytokine and chemo-
kine production and whether this activity could be modulated
by IFN-c, the main cytokine in coeliac disease. We also
analysed the potential role of CD 14 receptor and NF-jB
family members in the activation pathway.2. Materials and methods
2.1. Food proteins
Ovalbumin and soya proteins (Sigma, St. Louis, MO) were diluted
to 1 mg/ml concentration in incomplete RPMI-1640 medium (Endo-
toxin tested, Sigma), centrifuged (5000· g, 10 min) and supernatants
were stored at )20 C. The stock solution of crude gliadin 5.0 mg/ml inblished by Elsevier B.V. All rights reserved.
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(10 000· g, 10 min), the sediment was dissolved in HCl solution, the
concentration of soluble molecules was measured and the ﬁnal dilution
calculated.
Peptic fragments of proteins were prepared using the pepsin–agarose
gel (ICN, Biomedicals, OH, USA). 7 ml of protein (10 mg/ml) in 0.1 M
HCl, pH 1.8, was incubated with 5 ml of pepsin–agarose gel (45 min,
37 C). Removing the gel by centrifugation (1500· g, 10 min) stopped
enzymatic cleavage. The supernatants were then centrifuged
(12 000· g, 10 min) and soluble protein fragments divided into aliquots
and frozen at )20 C.
The gliadin 33-amino acid (AA) peptide [11], gliadin peptide p31-43
[6], and B peptide [4] were synthesised using the Fmoc/tBu protection
strategy on aminoethyl copoly (styrene-1% divinylbenzene) resin with
Knorr linker. After cleavage from the resin, the peptides were puriﬁed
using high-performance liquid chromatography and characterised by
AA analysis and liquid chromatography/mass spectrometry (System
Waters 2690 Separation Module and Waters 2487 Dual k Absorbance
Detector, connected to a Micromass Platform L.C.).
Potential presence of lipopolysaccharide (LPS) was tested using the
E-toxate test (Sigma). The LPS level in all reagents used in the study
was below the detection limit.2.2. Cell lines and their activation
THP-1 and U-937 cells (GCMCC, Braunschweig, Germany) were
cultured as described earlier [12]. Cells in concentration of 1 106/ml
were exposed to gliadin or its peptic fragments (10–500 lg/ml) alone
or together with human IFN-c (150 U/ml, R&D System, Minneap-
olis) or to LPS (Salmonella typhimurium, 1–10 lg/ml, Sigma) for 24 h.
THP-1 cells were also incubated with soya protein, ovalbumin or their
peptic fragments (100–500 lg/ml) or synthetic gliadin peptides [33 AA
gliadin peptide, B peptide and p31-43 peptide (200 lg/ml)] alone and/
or with IFN-c (150 U/ml). Alternatively, the cells were preincubated
with IFN-c for 2 or 24 h, washed twice with PBS and stimulated for
additional 24 h with gliadin digest alone or together with IFN-c. In
some experiments, THP-1 cells were preincubated for 1 h at 37 C
with mouse anti-CD14 monoclonal antibody (mAb) MEM-18 or with
isotype control IN-O5 mouse anti-insulin mAb (both mAb provided
by Prof. V. Horejsı); the gliadin fragments or LPS were then added to
cultured cells in the presence of anti-CD14 mAb or IN-O5 mAb for
24 h. Furthermore, NF-jB inhibitors sulfasalazine (0.1–2.0 mM),
pyrrolidine dithocarbamate (PDTC) (0.1–10 lM) and L-1-tosylamido-
2-phenylethyl chloromethyl ketone (TPCK) (1.0–25.0 lM) (Sigma)
were added to cultured cells for 30 min, and then gliadin digest was
added for 24 h.
2.3. Enzyme-linked immunosorbent assay
The level of IL-8 and TNF-a was determined in cell culture super-
natants collected after 6, 24 and 48 h of cultivation by enzyme-linked
immunosorbent assay DuoSet kit (R&D System, Minneapolis)
according to the manufacturer’s instructions.
2.4. Western blot analysis
THP-1 cells were stimulated for 30 min with gliadin digest
(200 lg/ml), IFN-c (150 U/ml) or LPS (1 lg/ml), rinsed in cold 1 lM
Na3VO4 in Tris buﬀered saline, lysed in ice-cold lysis buﬀer (25 mM
Tris–HCl, pH 7.4, 1 mM DTT, 1 mM Na3VO4 and 1% Nonidet P-40,
1 mM EDTA, 1 mM EGTA, 10 mM NaF and 1 mM PMSF) for
30 min at 4 C and centrifuged (14 000· g, 15 min, 4 C). Supernatants
were assayed for protein by the BCA protein kit (Pierce, USA). The
same amount of protein from each lysate (30 lg/well) was subjected to
10% SDS–polyacrylamide gel electrophoresis (PAGE) [13] and trans-
ferred onto nitrocellulose membranes. Phosphorylated IjB protein was
detected after incubation with rabbit anti-phospho-IjBa Abs (1:1000
ﬁnal dilution) (Cell Signaling, USA). The membrane was then incu-
bated with goat anti-rabbit horseradish peroxidase-conjugated Abs
(1:2500 ﬁnal dilution) (Cell Signaling, USA). Immunoreactive bands
were visualised by ECL detection kit (Amersham, UK) and quantiﬁed
by densitometry using Scan Pack 3.0 Software (Biometra, G€ottingen,
Germany).
2.5. Preparation of cell nuclear extract and colorimetric NF-jB assay
Nuclear extracts were prepared from THP-1 cells stimulated for 90
min with gliadin digest (500 lg/ml) alone or together with IFN-c (150
U/ml), sulfasalazine (2 mM), PDTC (0.5 lM) and TPCK (5 lM)using a Nuclear extract Kit (Active Motif, USA). NF-jB DNA
binding activity was detected using a TransAM NF-jB family tran-
scription factor assay kit (Active Motif, USA) according to the
manufacturer’s protocol. Brieﬂy, microwells coated with a double-
stranded oligonucleotide containing the NF-jB consensus sequence
were incubated with the nuclear extract for 1 h at room temperature
and washed three times with washing buﬀer. The captured active
transcription factor was incubated for 1 h with Ab speciﬁc for p65 or
p50 NF-jB subunit, then for 1 h with anti-rabbit IgG coupled-
horseradish peroxidase and after washing exposed to developing so-
lution for 10 min. The optical density was measured at 450 nm using
a Titertec Multiscan MCC/340 (Flow Lab., Irvine, Scotland).
2.6. Statistical analysis
Data are presented as arithmetic means of at least three independent
experiments+ S.E.M. Statistical analysis was performed by Student–
Newman–Keuls multiple range test and Student’s t-test. P values
smaller than 0.005 were considered to be signiﬁcant.3. Results and discussion
3.1. Cytokine production by human monocytic cell lines
stimulated with gliadin
Since the phenotypic and functional characteristics of hu-
man jejunal macrophages have not been precisely determined
in healthy and diseased conditions, the eﬀect of food proteins
was tested using human cell lines THP-1 and U-937. THP-1
and U-937 cells represent diﬀerent stages of monocyte/mac-
rophage maturation. Unlike the polyploid U-937 cells (CD 14-,
CD 68-), THP-1 cells (CD 14+, CD 68+) posseses a normal
complement of chromosomes and resemble primary monocyte-
derived macrophages in terms of inducible functions [14].
The crude gliadin had a very low direct eﬀect on the acti-
vation of THP-1 cells evaluated by IL-8 and TNF-a produc-
tion, while gliadin proteolytic fragments (100–500 lg/ml)
elicited a signiﬁcant secretion of both cytokines that was en-
hanced on its joint administration with IFN-c (150 U/ml).
Soya protein and ovalbumin, treated similarly to gliadin, had
no eﬀect on IL-8 and TNF-a production either when applied
alone or in combination with IFN-c (Fig. 1).
Since joint administration of IFN-c with gliadin fragments
enhanced the gliadin-induced production of IL-8 and TNF-a,
we investigated the eﬀect of IFN-c prestimulation (Fig. 2).
Interestingly, prestimulation of THP-1 cells with IFN-c
(150 U/ml) for 2 or 24 h prior to the addition of gliadin frag-
ments resulted also in a higher secretion of IL-8 and TNF-a
with respect to non-prestimulated cells (Fig. 2A and B). The
production of IL-8 and TNF-a was even higher when gliadin
fragments were applied to prestimulated cells simultaneously
with IFN-c. In contrast to THP-1 cells, the response of U-937
cells to gliadin fragments was very low and these cells produced
signiﬁcantly increased amount of IL-8 only when gliadin was
added to the cells prestimulated for 24 h with IFN-c (Fig. 2C).
The TNF-a production after gliadin challenge was not detect-
able (data not shown).
To complete the time schedule, the IL-8 and TNF-a secre-
tion by THP-1 cells was measured also 6 and 48 h after trig-
gering with gliadin fragments (200 lg/ml) alone or along with
IFN-c (150 U/ml). IL-8 production increased in time, reaching
a maximum value after 48 h of cultivation. TNF-a secretion
was elevated during the ﬁrst 24 h. Extension of the cultivation
to 48 h did not elevate cytokine secretion in response to gliadin
fragments and increased spontaneous release of TNF-a by cells
was observed (Fig. 3).
Fig. 2. Response of THP-1 (A, B) and U-937 cells (C) to gliadin
fragments added directly to cell cultures (a) or after preincubation with
IFN-c for 2 (b) or 24 h (c) measured as IL-8 (A, C) and TNF-a (B)
production. Data are expressed as means S.E.M. from at least three
independent experiments. * P < 0:05, ** P < 0:01.
Fig. 1. Eﬀect of gliadin, soya protein and ovalbumin and their prote-
olytic fragments on IL-8 (A) and TNF-a (B) secretion by THP-1 cells
measured after 24 h of cell cultivation (left); the synergistic eﬀect of
IFN-c applied together with food proteins (right). Data are expressed
as means S.E.M. from at least three independent experiments.
* P < 0:05, ** P < 0:01.
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AA peptide derived from a-gliadin (resistant to digestive
enzymes), described as an inducer of gliadin-speciﬁc T cells
[11], synthetic dodecapeptide B (FQQPQQQYPSSQ), a po-
tent mouse macrophage-stimulating peptide [4] and the glia-
din peptide (p31-43) that stimulates innate response in
cultivated coeliac biopsies [6]. The IL-8 production by THP-1
cells in response to the 33-AA peptide reached only about
20% and to the B peptide about 60% of the response detected
with the whole gliadin digest, while p31-43 gliadin peptide
exerted the same stimulatory capacity as the gliadin digest.
On evaluating TNF-a production, the B peptide reached
about 10% and p31-43 about 40% of the response detected
with the gliadin digest, while 33-AA peptide was unable to
induce TNF-a secretion even in combination with IFN-c.
Similarity in the synergistic eﬀect of IFN-c and gliadin-de-
rived peptide B, p31-43 and/or the whole gliadin digest on
cytokine secretion was observed (data not shown). These
results indicate that gliadin-derived peptides diﬀer in their
capacity to activate human monocytes and/or macrophages;
however, the whole gliadin digest was found to be the most
potent activator of these cells.3.2. The CD14 molecule is not involved in the activation of
THP-1 cells by gliadin
The response of THP-1 and U-937 cells to LPS (l lg/ml),
known to activate monocytes/macrophages, was compared
with activation by gliadin and/or IFN-c. When stimulated with
LPS, THP-1 cells produced signiﬁcantly higher levels of IL-8
(558.7 23.7 pg/ml) and TNF-a (107.3 13.0 pg/ml) than
U-937 cells (IL-8¼ 322.6 16.1 pg/ml; TNF-a¼ 33.5
5.2 pg/ml). The diﬀerences in response of THP-1 and U-937
Fig. 4. The involvement of NF-jB subunits p50 and p65 in the acti-
vation pathway induced by gliadin fragments in THP-1 cells. The NF-
jB DNA binding activity and the eﬀect of inhibitors: sulfasalazine (2
mM), PDTC (0.5 lM) and TPCK (5 lM) was measured after a 90 min
cultivation by a colorimetric NF-jB assay. Data are presented as
means S.E.M. from three independent experiments. * P < 0:05,
** P < 0:01 was calculated vs. untreated cells and s P < 0:01,
ss P < 0:01 vs. gliadin-stimulated cells.
Fig. 3. The kinetics of IL-8 (A) and TNF-a (B) production by THP-1
cells. Cytokine production was determined 6, 24 and 48 h after addi-
tion of gliadin fragments and/or IFN-c to cells directly or after IFN-c-
preincubation (for 2 or 24 h). Data obtained from at least three
experiments are expressed as means S.E.M; diﬀerences between val-
ues at individual time intervals were calculated by Student’s t-test.
* P < 0:05, ** P < 0:01, *** P < 0:001.
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Escherichia coli LPS and puriﬁed Shiga-like toxins [15,16].
Since the more pronounced response of THP-1 cells seemed
to be in accordance with the higher expression of CD14 mol-
ecule, we examined the eﬀect of anti-CD14 mAb on cytokine
production. Addition of anti-CD14 mAb to THP-1 cells sub-
stantially reduced the IL-8 production induced by LPS, but
had no eﬀect on the activation by gliadin digest (Table 1). This
observation throws doubt on the potential role of CD14
molecule in the activation of cells with gliadin.
3.3. Gliadin-induced IL-8 secretion is mediated via NF-jB
pathway
Stimulation of THP-1 cells with gliadin digest (500 lg/ml)
and/or with IFN-c (150 U/ml) resulted in a marked increase of
the binding activities of NF-jB subunits p50 and p65, moreTable 1
Anti-CD14 mAb (MEM-18) blockade of IL-8 production by LPS and gliad
IL-8 secretion (pg/ml)
mAb added +MEM-18 (10
LPS 10 lg 1030.3 130.0 324.4 76.8 (7
Gliadin 500 lg 287.5 21.2 273.1 11.0 (5
Cells 98.0 11.8 100.2 10.5 (0
Note. Data are shown as means S.E.M. MEM-18, anti-CD14 monoclonalpronounced in the case of p50 subunit. To conﬁrm the role of
NF-jB in gliadin-induced activation of THP-1 cells, we ex-
amined the eﬀects of NF-jB inhibitors: sulfasalazine, PDTC
and TPCK. Sulfasalazine inhibits phosphorylation of Ij-B
[17], PDTC functions as a NF-jB inhibitor by blocking the
dissociation of the NF-jB/IjB complex [18] and TPCK plays a
role as proteasome inhibitor; it can therefore inactivate NF-jB
by preventing the degradation of IjB [19]. Treatment with
0.5 lM PDTC and 2 mM sulfasalazine inhibited substantially
p65 but only slightly p50 binding activity; 5 lM TPCK re-
duced the p50 binding capacity more eﬃciently than that of
p65 (Fig. 4).
Moreover, sulfasalazine markedly suppressed, in a dose-
dependent fashion, gliadin-stimulated IL-8 secretion by THP-1
cells, producing 15% inhibition at 0.1 mM and 90% inhibition
at 2 mM concentration. The eﬀect of PDTC was ﬁrst evident at
0.1 lM concentration. TPCK produced 32% inhibition at
1 lM and completely abolished IL-8 production at 25 lM
concentration (data not shown).
Since NF-jB activation involves the phosphorylation and
subsequent degradation of IjBa, we assayed the phosphory-
lation of IjBa by Western blot analysis. Fig. 5 shows that the
treatment of THP-1 cells with gliadin alone or together with
IFN-c increased phosphorylation of IjBa, when compared
with unstimulated cells. Taken together, these results suggest
that NF-jB molecule containing p50 and p65 subunits is in-
volved in the activation pathway triggered by gliadin frag-
ments in human monocytes.
In summary, our results document for the ﬁrst time the di-
rect eﬀect of gliadin on human monocytes. In contrast to soyain-stimulated THP-1 cells
lg) (% of blockade) + IN-05 (10 lg) (% of blockade)
0) 1038.4 56.6 (0)
) 300.5 20.2 (0)
) 98.2 15.6 (0)
antibody IN-05, anti-insulin control monoclonal antibody.
Fig. 5. Representative Western blot shows the eﬀect of gliadin frag-
ments, IFN-c or LPS (positive control) on phosphorylation of IjBa in
THP-1 cells (p-IjBa formation) (A) and its densitometric evaluation
presented as mean AUC (arbitrary units)S.E.M. of three indepen-
dent experiments, ** P < 0:01 (B).
L. Jelınkova et al. / FEBS Letters 571 (2004) 81–85 85protein and ovalbumin, gliadin and its fragments stimulated
human monocytes to increased IL-8 and TNF-a production.
IFN-c, the main cytokine produced by gluten-speciﬁc T cells of
coeliac patients, exerted a costimulatory eﬀect on chemokine
and cytokine production. Moreover, the data from our on-
going experiments show that gliadin peptides also activate
human peripheral blood monocytes and that the production of
IL-8 and TNF-a signiﬁcantly diﬀers in cells isolated from
healthy donors and coeliac patients. The analysis of factors
aﬀecting the responsiveness is under study. Based on these
ﬁndings, it could be suggested that increased secretion of IL-8
(a chemokine attracting immune cells to inﬂamed tissue) and
TNF-a (cytokine involved in the activation of metallopro-
teinases digesting tissue components) produced by activated
monocytes and/or macrophages could be involved in the im-
pairment of coeliac intestinal mucosa.
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